Evolus, Inc. (EOLS)
NASDAQ: EOLS · Real-Time Price · USD
5.27
+0.05 (0.96%)
At close: Apr 28, 2026, 4:00 PM EDT
5.31
+0.04 (0.76%)
After-hours: Apr 28, 2026, 5:36 PM EDT
Evolus Employees
Evolus had 334 employees as of December 31, 2025. The number of employees increased by 2 or 0.60% compared to the previous year.
Employees
334
Change (1Y)
2
Growth (1Y)
0.60%
Revenue / Employee
$889,749
Profits / Employee
-$154,614
Market Cap
342.87M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Organigram Global | 1,137 |
| Aurora Cannabis | 1,073 |
| Canopy Growth | 960 |
| Emergent BioSolutions | 900 |
| Organogenesis Holdings | 854 |
| Kamada | 462 |
| Esperion Therapeutics | 294 |
| Anika Therapeutics | 235 |
EOLS News
- 14 days ago - Evolus Transcript: 25th Annual Needham Virtual Healthcare Conference - Transcripts
- 14 days ago - Evolus to Report First Quarter Financial Results on May 4, 2026 - Business Wire
- 4 weeks ago - Evolus to Participate in the Needham 25th Annual Virtual Healthcare Conference - Business Wire
- 5 weeks ago - Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 6 weeks ago - Evolus Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Evolus Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - Evolus Reports Fourth Quarter and Full-Year 2025 Financial Results; Delivers Sixth Consecutive Year of Double-Digit Growth and Expects Sustainable Profitability1 Beginning in 2026 - Business Wire
- 2 months ago - Evolus to Participate in The Leerink Partners Global Healthcare Conference - Business Wire